Business
Teva declined the chance because it does not operate in the store-brand OTC market, Perrigo's main activity.
Hi, what are you looking for?
Jewish Business News
Business
Mylan's filing on executive compensation reveals much higher pay than at Teva.
Business
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.
Business
Comverse, formerly one of Israel’s flagship high-tech companies in the process of divesting its assets, is asking $400 million.
Money
The former president and CEO Teva Americas Generics earned $7.3 million in 2014.
Business
Copaxone’s patent remains in force at least until the Federal Circuit Appeals Court reconsiders the case. The rivals of Teva Pharmaceutical Industries Ltd. (NYSE:...
Money
The venture capital fund only invested a few million dollars in the Israeli DIY website company. More than four years after its initial investment...
Business
At the end of 2012, Eden Energy Discoveries Ltd. (TASE: EDN) paid $10.5 million for 8.7% of the share capital of Genesis Energy,...
Business
– Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. – After years of...
Business
– Israel Chemicals will set up a joint venture with Yunnan Yuntianhua and hold a 15% stake in the Chinese company. – Idan...